Intercept Pharmaceuticals Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	Current	FY 2010	FY 2009	FY 2008	FY 2007	FY 2006
Period Ending	Aug '25 Aug 1, 2025	Dec '10 Dec 31, 2010	Dec '09 Dec 31, 2009	Dec '08 Dec 31, 2008	Dec '07 Dec 31, 2007	Dec '06 Dec 31, 2006
Market Capitalization	31	43	-	-	-	-
Enterprise Value	-	42	-	-	-	-
Last Close Price	0.15	0.50	-	-	-	-
PS Ratio	79.10	135.54	-	-	-	-
PB Ratio	-104.94	456.14	-	-	-	-
P/TBV Ratio	-	6093.35	-	-	-	-
EV/Sales Ratio	-	133.94	-	-	-	-
Asset Turnover	1.17	2.02	-	-	9.00	-
Quick Ratio	0.04	0.22	0.13	159.53	11.89	0.33
Current Ratio	0.04	0.22	0.13	176.96	11.89	0.33
Return on Equity (ROE)	-1302.44%	-	-	-	15.75%	-
Return on Assets (ROA)	-362.58%	-677.79%	-560.81%	-	11.37%	-
Return on Capital (ROIC)	-404.49%	-	-	-	13.44%	-
Return on Capital Employed (ROCE)	-	-	-	-	12.30%	61.70%
Earnings Yield	-7.48%	-4.69%	-	-	-	-
FCF Yield	-7.32%	-5.30%	-	-	-	-
Buyback Yield / Dilution	-25.73%	-269.77%	-	-28.94%	-46.33%	-

Updated Nov 10, 2011. Source: S&P Global Market Intelligence. Standard template. Financial Sources.